Korean Joint Registry for Alzheimer's Treatment and Diagnostics (JOY-ALZ)

Summary

The purpose of this research is to investigate the long-term effectiveness and safety of new Alzheimer's disease treatments, particularly monoclonal antibody therapies like lecanemab and donanemab, as well as to enhance diagnostic methods for Alzheimer's disease by collecting real-world data from Korean Alzheimer's patients. The goal is to contribute to the precision of Alzheimer's treatment and to evaluate the impact of these new therapies and diagnostic techniques in clinical practice.

Conditions

• Mild Cognitive Impairment
• Dementia
• Subjective Cognitive Decline (SCD)
• Alzheimer Disease

Sponsors & Collaborators

• Korean Dementia Association

  collaborator UNKNOWN

• Inha University Hospital

  collaborator OTHER

• Gachon University Gil Medical Center

  collaborator OTHER

• Saint Vincent's Hospital, Korea

  collaborator OTHER

• Gangnam Severance Hospital

  collaborator OTHER

• Konkuk University Hospital

  collaborator OTHER

• Kyunghee University Medical Center

  collaborator OTHER

• Korea University Medicine

  collaborator UNKNOWN

• Busan University Medical Center

  collaborator UNKNOWN

• CHA University

  collaborator OTHER

• Samsung Medical Center

  collaborator OTHER

• Seoul National University Hospital

  collaborator OTHER

• Seoul National University Bundang Hospital

  collaborator OTHER

• Asan Medical Center

  collaborator OTHER

• Soonchunhyang University Hospital

  collaborator OTHER

• Ajou University Hospital, Suwon, South Korea

  collaborator UNKNOWN

• Yonsei University Yongin Severance Hospital

  collaborator UNKNOWN

• Wonkwang University Hospital

  collaborator OTHER

• Ewha Womans University Seoul Hospital

  collaborator OTHER

• InjeUniversityBusanPaikHospital

  collaborator UNKNOWN

• Chonnam National University Hospital

  collaborator OTHER

• Jeju National University Hospital

  collaborator OTHER

• Chungnam National University Hospital

  collaborator OTHER

• Gyungbook national university hospital

  collaborator UNKNOWN

• Hanllym University Medical Center

  collaborator UNKNOWN

• Heavenly Clinical Research

  collaborator OTHER

• KangWon National University Hospital

  collaborator OTHER

• Seoul St. Mary's Hospital, The Catholic University

  collaborator UNKNOWN

• Ewha Womans University Mokdong Hospital

  lead OTHER

Principal Investigators

• Geon-ha Kim · Ewha Womans University Mokdong Hospital

• Seong-hye Choi · Inha University Hospital

• Kee-hyung Park · Gachon University Gil Medical Center

Eligibility

Min Age

19 Years

Sex

ALL

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2025-02-24

Primary Completion

2034-12-31

Completion

2034-12-31

Countries

• South Korea

Study Locations